Health

Picarro Appoints Haavard Oestensen Chief Commercial and Product Officer to Lead Market-Focused Growth and Launch of Fenceline Solution

SANTA CLARA, Calif., Jan. 27, 2026 /PRNewswire/ -- Picarro, Inc. , a global leader in real-time emissions monitoring and advanced gas analysis solutions, today announced the...

2026-01-27 00:10 5576

Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning

SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology today announced a strategic partnership with WPP Group, a leading creative transformation company that provides integrated brand, media, public relations, data, and technology solutions worldwide. Headquartered in London, WPP Group oper...

2026-01-26 22:48 10576

BIOSeedin Winter Innovation Partnering Summit:J.P.Morgan Spotlight

SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- To enable Chinese innovative pharmaceutical companies to more efficiently connect with international resources, bioSeedin, a platform facilitating cooperation in innovative drug assets, hosted the BIOSeedin Winter Innovation Partnering Summit inSan Fra...

2026-01-26 22:00 6711

Jin Medical International Ltd. To Host Management Fireside Chat

CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment inChina, announced today that its Chief Executive Officer, tog...

2026-01-26 21:57 19538

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated mil...

2026-01-26 20:00 2969

Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Advance Traditional Chinese Medicine Research and Education in Singapore

SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched theGu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part ...

2026-01-26 18:00 5161

WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline

SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and auto...

2026-01-26 17:35 15553

HKUST President Prof. Nancy IP Engages in Global Dialogues at Davos 2026 on Neuroscience, University Leadership, and the Future of Research

HONG KONG, Jan. 26, 2026 /PRNewswire/ -- Prof. Nancy IP, President of The Hong Kong University of Science and Technology (HKUST), joined global leaders at the World Economic Forum (WEF) Annual Meeting 2026 in Davos-Klosters, Switzerland. As the sole university president representing Hong Kong, sh...

2026-01-26 15:43 5646

HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline

SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research, Developm...

2026-01-26 15:00 10161

Get Exclusive Limited-Edition Gifts During Your Lunar New Year Trip: Wakamoto Launches "Thank You from Wakamoto" Campaign

TOKYO, Jan. 26, 2026 /PRNewswire/ -- Wakamoto Pharmaceutical Co., Ltd. (Tokyo, Arata Igarashi), a company dedicated to supporting healthy and active lifestyles, will launch a nationwide campaign in which customers who purchase "Strong Wakamoto" will receive an original hand towel.

2026-01-26 13:00 5076

Natural Good Things Achieves Major Success with Taiwanese Artist Halo Mavis, Records 250,000 Live Commerce Sales

SEOUL, South Korea, Jan. 26, 2026 /PRNewswire/ -- Women's wellness inner-care brand Natural Good Things (NGT) is making significant strides in the global market through a strategic partnershipwith Taiwanese artist and mega influencer Halo Mavis. NGT announced that it achieved cumulative sales of...

2026-01-26 11:00 4801

AXA Completes Re-domiciliation to Hong Kong

HONG KONG, Jan. 26, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") is pleased to announce the successful completion of the re-domiciliation of AXA China Region Insurance Company (Bermuda) Limited ("the Company") from Bermuda to Hong Kong, under the re-domiciliation regime introduced by Hong...

2026-01-26 10:05 7785

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

-Topline data from the Phase II study for the treatment of diabetes are  expected in the third quarter of 2026. -ASC30 demonstrated placebo-adjusted weight loss of up to 7.7% in a recently completed 13-week U.S. Phase II study in participants with obesity or o verweight, withbetter gastrointestina...

2026-01-26 08:10 9021

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and Drug Administration (FDA). The agency's Master ...

2026-01-26 08:00 6304

Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor

* Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study inthe United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles. * ISM8969 is a novel oral therapeutic candi...

2026-01-23 21:30 14408

Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026

DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution atWHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how dia...

2026-01-23 18:00 6440

The American Chamber of Commerce in Singapore (AmChamSG) Supports Blossom Seeds with Outreach to 400 Senior Households in Sembawang

Nearly 100 AmChamSG Members and Staff Commemorate Martin Luther King, Jr. Day of Service (MLK Day) by Supporting Senior Heartlanders in Need SINGAPORE, Jan. 23, 2026 /PRNewswire/ -- The American Chamber of Commerce in Singapore (AmChamSG) commemorated Martin Luther King, Jr. Day of Service (MLK ...

2026-01-23 17:15 10506

Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.

AUCKLAND, New Zealand, Jan. 21, 2026 /PRNewswire/ -- Aroa Biosurgery Limited is pleased to announce that the latest publication from its ongoing prospective study, theMyriad Augmented Soft Tissue Reconstruction Registry (MASTRR), has been published in theJournal of Trauma and Injury. MASTRR is t...

2026-01-23 03:13 5304

Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines

* New "AI GYM for Science" dramatically boosts the biological and chemical intelligence of any causal or frontier LLM * Up to 10x performance gains on key drug discovery benchmarks compared to LLMs that miss the mark on ~75–95% of tasks * Advances Insilico's vision of Pharmaceutical Superint...

2026-01-22 22:37 9296

Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation

SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ -- May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company's strategic vision for the next decade centered on three core...

2026-01-22 22:11 16779
1 ... 35363738394041 ... 872

Week's Top Stories